Vanguard Asset Management »

Catalyst Pharmaceutical Partners shares owned by Vanguard Asset Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Vanguard Asset Management from 13F filings

Historical chart of Vanguard Asset Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Vanguard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Vanguard Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.9M 77k 24.76

More positions owned by Vanguard Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Astrazeneca Ord (AZN)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Johnson & Johnson (JNJ)

View all positions for Vanguard Asset Management

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Vanguard Capital Management
Deerfield Management Company
Dimensional Fund Advisors
Fundsmith
Bank of America Corporation
American Century Companies
Geode Capital Management
Morgan Stanley
Renaissance Technologies
Vanguard Portfolio Management
Royce & Associates
Henderson Group

View all funds holding Catalyst Pharmaceutical Partners